SK279902B6 - Triazolpyrimidínové deriváty, farmaceutický prostr - Google Patents

Triazolpyrimidínové deriváty, farmaceutický prostr Download PDF

Info

Publication number
SK279902B6
SK279902B6 SK2078-92A SK207892A SK279902B6 SK 279902 B6 SK279902 B6 SK 279902B6 SK 207892 A SK207892 A SK 207892A SK 279902 B6 SK279902 B6 SK 279902B6
Authority
SK
Slovakia
Prior art keywords
methyl
propyl
formula
tetrazolyl
pyrimidine
Prior art date
Application number
SK2078-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK207892A3 (en
Inventor
Nicole Bru-Magniez
Eric Nicolai
Jean-Marie Teulon
Original Assignee
Laboratoires Upsa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Upsa filed Critical Laboratoires Upsa
Publication of SK207892A3 publication Critical patent/SK207892A3/sk
Publication of SK279902B6 publication Critical patent/SK279902B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK2078-92A 1991-07-05 1992-07-02 Triazolpyrimidínové deriváty, farmaceutický prostr SK279902B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9108486A FR2678618B1 (fr) 1991-07-05 1991-07-05 Nouveaux derives de triazolo pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.

Publications (2)

Publication Number Publication Date
SK207892A3 SK207892A3 (en) 1995-08-09
SK279902B6 true SK279902B6 (sk) 1999-05-07

Family

ID=9414783

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2078-92A SK279902B6 (sk) 1991-07-05 1992-07-02 Triazolpyrimidínové deriváty, farmaceutický prostr

Country Status (23)

Country Link
US (1) US5217973A (da)
EP (1) EP0521768B1 (da)
JP (1) JP3140566B2 (da)
KR (1) KR100243628B1 (da)
AT (1) ATE101153T1 (da)
AU (1) AU655288B2 (da)
CA (1) CA2072233C (da)
CZ (1) CZ284757B6 (da)
DE (1) DE69200045T2 (da)
DK (1) DK0521768T3 (da)
EE (1) EE03003B1 (da)
ES (1) ES2063570T3 (da)
FR (1) FR2678618B1 (da)
HU (2) HU220225B (da)
IE (1) IE65635B1 (da)
IL (1) IL102367A (da)
LV (1) LV10717B (da)
MD (1) MD523G2 (da)
NZ (1) NZ243443A (da)
RU (1) RU2103270C1 (da)
SK (1) SK279902B6 (da)
TW (1) TW221445B (da)
ZA (1) ZA924954B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358950A (en) * 1991-07-05 1994-10-25 Laboratoires Upsa Triazolopyrimidine derivatives which are angiotensin II receptor antagonists
FR2687677B1 (fr) * 1992-02-24 1996-10-11 Union Pharma Scient Appl Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
US5389632A (en) * 1992-02-24 1995-02-14 Laboratoires Upsa Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
US5387747A (en) * 1992-02-24 1995-02-07 Laboratoires Upsa Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present
IT1263804B (it) * 1993-01-22 1996-09-03 Luso Farmaco Inst Derivati pirimidinonici fusi con eterocicli azotati ad attivita' a ii antagonista
US5358947A (en) * 1993-09-13 1994-10-25 American Cyanamid Company Angiotensin II receptor blocking 2,3-substituted pyrazolo[1,5-a]-1,3,5-triazin-4(3H)-ones
EP0976753B1 (en) * 1997-03-24 2004-01-02 Kyowa Hakko Kogyo Co., Ltd. [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2009158309A2 (en) * 2008-06-25 2009-12-30 Ligand Pharmaceuticals Inc. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
CA3235663A1 (en) * 2021-10-19 2023-04-27 Impact Therapeutics (Shanghai), Inc. Substituted triazoloheteroaryl compounds as usp1 inhibitors and the use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US269980A (en) * 1883-01-02 Horse power
GB859287A (en) * 1958-10-03 1961-01-18 Ici Ltd Triazolopyrimidine derivatives and their preparation
GB897870A (en) * 1959-06-15 1962-05-30 Ici Ltd s-triazolo[2, 3-c]pyrimidine derivatives
GB951652A (en) * 1960-06-28 1964-03-11 Wallace Broadbent Sulphamyl triazolopyrimidines and their preparation
US4269980A (en) * 1979-12-17 1981-05-26 American Cyanamid Company (Substituted-phenyl)-1,2,4-triazolo[4,3-c]pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-c]pyrimidines
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
US4528288A (en) * 1983-05-02 1985-07-09 Riker Laboratories, Inc. Substituted triazolo[1,5-c]pyrimidines
US4532242A (en) * 1983-05-02 1985-07-30 Riker Laboratories, Inc. Substituted triazolo[4,3-c]pyrimidines
US4562192A (en) * 1984-02-03 1985-12-31 G. D. Searle & Co. 6-Substituted-5-phenyltetrazolo[1,5-a][1,2,4]triazole[1,5-c]pyrimidines, and pharmaceutical compositions containing them
US4728652A (en) * 1985-05-20 1988-03-01 E. R. Squibb & Sons, Inc. 2-substituted thio or oxy-4-aryl or heterocyclo-5-carboxy-1,4-dihydropyrimidines, composition containing them, and method of using them to reduce blood pressure
US5010195A (en) * 1988-05-25 1991-04-23 The Dow Chemical Company Herbicidal alkoxy-1,2,4-triazolo(1,5-c)primidine-2-sulfonamides
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
EP0435827A3 (en) * 1989-12-28 1991-11-13 Ciba-Geigy Ag Diaza compounds
EP0522038A4 (en) * 1990-03-30 1993-05-26 Merck & Co. Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
US5177206A (en) * 1991-10-08 1993-01-05 Dowelanco Process for the preparation of substituted N-(aryl)-1,2,4-triazolopyrimidine-2-sulfonamides

Also Published As

Publication number Publication date
DK0521768T3 (da) 1994-08-15
DE69200045D1 (de) 1994-03-17
LV10717B (en) 1995-12-20
FR2678618A1 (fr) 1993-01-08
IE65635B1 (en) 1995-11-01
HU220225B (hu) 2001-11-28
IL102367A0 (en) 1993-01-14
DE69200045T2 (de) 1994-05-19
US5217973A (en) 1993-06-08
MD523F1 (en) 1996-04-30
CZ207892A3 (en) 1993-01-13
MD523G2 (ro) 1997-01-31
AU1939692A (en) 1993-01-07
CA2072233A1 (en) 1993-01-06
AU655288B2 (en) 1994-12-15
EP0521768B1 (fr) 1994-02-02
ZA924954B (en) 1993-04-28
KR930002349A (ko) 1993-02-23
EP0521768A1 (fr) 1993-01-07
IE922015A1 (en) 1993-01-13
SK207892A3 (en) 1995-08-09
HU9202227D0 (en) 1992-10-28
JP3140566B2 (ja) 2001-03-05
HU211473A9 (en) 1995-11-28
NZ243443A (en) 1995-01-27
FR2678618B1 (fr) 1993-11-05
ES2063570T3 (es) 1995-01-01
CZ284757B6 (cs) 1999-02-17
KR100243628B1 (ko) 2000-03-02
LV10717A (lv) 1995-06-20
EE03003B1 (et) 1997-06-16
IL102367A (en) 1997-06-10
TW221445B (da) 1994-03-01
CA2072233C (en) 2003-11-18
JPH06122685A (ja) 1994-05-06
HUT63422A (en) 1993-08-30
ATE101153T1 (de) 1994-02-15
RU2103270C1 (ru) 1998-01-27

Similar Documents

Publication Publication Date Title
SK279902B6 (sk) Triazolpyrimidínové deriváty, farmaceutický prostr
CA1307786C (en) Quinazoline derivatives and antihypertensive preparations containing same as effective components
ES2358424T3 (es) Derivados de pirimidina útiles para el tratamiento de enfermedades mediadas por crth2.
CA1300624C (en) 2-pyrimidinyl-1-piperazine derivatives, processes for their preparation and medicaments containing them
JP4987871B2 (ja) Ｐ２ｘ３アンタゴニストとしてのピペリジン及びピペラジン誘導体
IE901258L (en) Pyrimidine derivatives
CA2178548A1 (en) Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydro-quinazolinedione derivatives as .alpha.1 adrenergic receptor antagonists
JPH0794447B2 (ja) キナゾリン誘導体
HRP20020327A2 (en) Alkylamino substited bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
EP0244176A2 (en) Thienopyrimidine-2,4-dione derivatives and intermediates thereof
AU2009232721A1 (en) Pyrimidine derivative having cell protecting effect and uses thereof
OA12823A (en) Peptide deformylase inhibitors.
EP1644342A1 (en) Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
Nicolai et al. Synthesis and SAR studies of novel triazolopyrimidine derivatives as potent, orally active angiotensin II receptor antagonists
US4666915A (en) 2-anilino-1,6-dihydro-6-oxo-5-pyrimidine-carboxylic acid derivatives, process for the preparation thereof, and antiallergic agent containing the same
US3498984A (en) 4-amino-2-phenyl-6-thiopyrimidines
RU2116308C1 (ru) Триазолпиримидиновые производные и фармацевтическая композиция
HUT50477A (en) Process for producing tricyclic condensed pyrimidine derivatives and pharmaceutical compositions comprising such compounds
US4608375A (en) Quinazolinone derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
CA1173831A (en) Process for the manufacture of novel polyazaheterocyclic compounds
US3320256A (en) Fluorinated imidazoo[1, 2-c]pyrimidines and pyrimido[1, 2-c]pyrimidines
NZ207349A (en) Triazolo(4,3-c)pyrimidines and triazolo(1,5-c)pyrimidines and pharmaceutical compositions
US3498983A (en) 7,8-dihydroxybenzo(g)pteridine-6,9-diones and derivatives
Twomey Nucleophilic Cleavage of s-Triazolophthalazinone Derivatives

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20120702